Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan 80 mg + Hydrochlorothiazide 25 mg

This study has been completed.

Study NCT00267943 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: December 21, 2005 Last Updated: October 7, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2007
Estimated Primary Completion Date:	No date given

No publications provided by Boehringer Ingelheim Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Neldam S, Edwards C. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication. Expert Opin Pharmacother. 2009 Feb;10(3):345-52.